Chronic Lymphocytic Leukemia

Practice-Changing Results With Ibrutinib–Rituximab Combo in Young Patients With CLL

12/14/2018

Survival outcomes of ibrutinib–rituximab therapy in young, treatment-naïve patients with CLL outshined rates seen with the gold standard of care regimen.

Survival outcomes of...

12/14/2018

Oncology

Ibrutinib–Obinutuzumab Combination a Promising First-Line Therapy Option for CLL and SLL

11/30/2018

Results from a recent trial highlight the promising potential of obinutuzumab plus ibrutinib as a promising new first-line treatment option for patients with CLL or SLL.

Results from a recent trial...

11/30/2018

Oncology

Venetoclax Promising in the Treatment of CLL

10/19/2018

At L&M 2018, Richard R. Furman, MD, discussed venetoclax in the treatment of patients with chronic lymphocytic leukemia.

At L&M 2018, Richard R. Furman,...

10/19/2018

Oncology